TG Therapeutics: 2Q Earnings Snapshot
NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Friday reported a loss of $36.2 million in its second quarter.
The New York-based company said it had a loss of 42 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.
The biopharmaceutical company posted revenue of $38,000 in the period.
TG Therapeutics shares have risen 68% since the beginning of the year. The stock has decreased 40% in the last 12 months.